Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=27125377
&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215
Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 247.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 247.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 247.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 247.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 247.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 247.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 247.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 247.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 247.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 247.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\27125377
.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117 J+Cell+Commun+Signal
2016 ; 10
(2
): 143-51
Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Engagement of CD22 on B cells with the monoclonal antibody epratuzumab stimulates
the phosphorylation of upstream inhibitory signals of the B cell receptor
#MMPMID27125377
Lumb S
; Fleischer SJ
; Wiedemann A
; Daridon C
; Maloney A
; Shock A
; Dörner T
J Cell Commun Signal
2016[Jun]; 10
(2
): 143-51
PMID27125377
show ga
The binding of antigen to the B cell receptor (BCR) results in a cascade of
signalling events that ultimately drive B cell activation. Uncontrolled B cell
activation is regulated by negative feedback loops that involve inhibitory
co-receptors such as CD22 and CD32B that exert their functions following
phosphorylation of immunoreceptor tyrosine-based inhibition motifs (ITIMs). The
CD22-targeted antibody epratuzumab has previously been shown to inhibit
BCR-driven signalling events, but its effects on ITIM phosphorylation of CD22 and
CD32B have not been properly evaluated. The present study therefore employed both
immunoprecipitation and flow cytometry approaches to elucidate the effects of
epratuzumab on direct phosphorylation of key tyrosine (Tyr) residues on both
these proteins, using both transformed B cell lines and primary human B cells.
Epratuzumab induced the phosphorylation of Tyr(822) on CD22 and enhanced its
co-localisation with SHP-1. Additionally, in spite of high basal phosphorylation
of other key ITIMs on CD22, in primary human B cells epratuzumab also enhanced
phosphorylation of Tyr(807), a residue involved in the recruitment of Grb2. Such
initiation events could explain the effects of epratuzumab on downstream
signalling in B cells. Finally, we were able to demonstrate that epratuzumab
stimulated the phosphorylation of Tyr(292) on the low affinity inhibitory Fc
receptor CD32B which would further attenuate BCR-induced signalling. Together,
these data demonstrate that engagement of CD22 with epratuzumab leads to the
direct phosphorylation of key upstream inhibitory receptors of BCR signalling and
may help to explain how this antibody modulates B cell function.